FDA Inspection 1229984 — Juno Therapeutics, Inc.
The FDA completed an inspection of Juno Therapeutics, Inc. on September 24, 2024 in Bothell, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 24, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Bothell, WA (United States)